News

Scientists have discovered a new type of immune defense in E. coli bacteria that turns viral infection machinery against the ...
UC San Diego researchers reveal PHGDH as a causal gene in Alzheimer's, linking its regulatory role to disease progression and ...
Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of ...
A novel drug combination targeting LSD1 and GSK3 shows promise in treating acute myeloid leukemia by promoting cell ...
XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused ...